Source: Eur Respir Rev 2011; 20: 114-117
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Egan J.J.. Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient. Eur Respir Rev 2011; 20: 114-117

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias Source: ERJ Open Res, 5 (2) 00045-2019; 10.1183/23120541.00045-2019 Year: 2019 Considerations of a warm autopsy program for patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis Source: Eur Respir J, 54 (6) 1901188; 10.1183/13993003.01188-2019 Year: 2019 Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis Source: Eur Respir Rev 2014; 23: 3-4 Year: 2014 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Approach to diagnosis of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Follow-up and nonpharmacological management of the IPF patient Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010 Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Steroid osteoporosis prevention in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 The diagnostic role of cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013 The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Eur Respir J, 51 (1) 1702596; 10.1183/13993003.02596-2017 Year: 2018 Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The effectiveness of pulmonary rehabilitation in patients diagnosed with interstitial pulmonary fibrosis Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Towards a better diagnosis of idiopathic pulmonary fibrosis Source: Eur Respir Rev 2011; 20: 108-113 Year: 2011 Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021